Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7512977 | International Journal of Drug Policy | 2016 | 6 Pages |
Abstract
This study represents an updated, comprehensive assessment of Global Fund investments in harm reduction from its founding (2002) until the start of the new funding model (2014). It also highlights the overall shortfall of harm reduction funding, with the estimated global need being US$ 2.3Â billion for harm reduction in 2015 alone. Using this baseline, the Global Fund must carefully monitor its new funding model and ensure that investments in harm reduction are maintained or scaled-up. There are widespread concerns regarding the withdrawal from middle-income countries where harm reduction remains essential and unfunded through other sources: for example, 15% of the identified investments were for countries which are now ineligible for Global Fund support.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Jamie Bridge, Benjamin M. Hunter, Eliot Albers, Catherine Cook, Mauro Guarinieri, Jeffrey V. Lazarus, Jack MacAllister, Susie McLean, Daniel Wolfe,